WA SB5507 | 2021-2022 | Regular Session

Status

Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: Introduced on January 10 2022 - 25% progression, died in committee
Action: 2022-01-10 - First reading, referred to Health & Long Term Care.
Pending: Senate Health & Long Term Care Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Exempting a manufacturer of certain dialysate and dialysis devices used by home dialysis patients or a manufacturer's agent from the pharmacy practices act and legend drug act.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Exempting a manufacturer of certain dialysate and dialysis devices used by home dialysis patients or a manufacturer's agent from the pharmacy practices act and legend drug act.

Sponsors


History

DateChamberAction
2022-01-10SenateFirst reading, referred to Health & Long Term Care.
2021-12-07SenatePrefiled for introduction.

Same As/Similar To

HB1675 (Crossfiled) 2022-03-11 - Effective date 6/9/2022.

Subjects


Code Citations

ChapterArticleSectionCitation TypeStatute Text
1864257Amended CodeSee Bill Text
6941032Amended CodeSee Bill Text

Washington State Sources


Bill Comments

feedback